Navigation Links
IRIDEX Announces First Quarter 2009 Conference Call and Release Date
Date:5/7/2009

MOUNTAIN VIEW, Calif., May 7 /PRNewswire-FirstCall/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced that it will release its first quarter 2009 financial results after the market closes on Thursday, May 14, 2009. In conjunction with the release, the Company will host a conference call with the investment community at 5:00 p.m. Eastern Time on Thursday, May 14, 2009 to discuss the results of the quarter and other business developments.

Interested parties may access the live conference call via telephone by dialing (877) 941-9205 U.S. or (480) 629-9041 (International) and quoting Conference ID 4075884, or by visiting the Company's website at www.iridex.com. A telephone replay will be available beginning on Thursday, May 14, 2009 through Thursday, May 21, 2009 by dialing (800) 406-7325 (US) or (303) 590-3030 (International) and entering Access Code 4075884.

About IRIDEX

IRIDEX Corporation is a leading worldwide provider of therapeutic based laser systems, consumable laser probes and delivery devices to treat eye diseases in ophthalmology and skin disorders in the aesthetics market. IRIDEX products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 100 independent distributors into 107 countries. For further information, visit the Company's website at www.iridex.com.


'/>"/>
SOURCE IRIDEX Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. IRIDEX Announces Closing of $5.0 Million Private Placement
2. William Moore Appointed to IRIDEX Board of Directors
3. IRIDEX Appoints Burr, Pilger & Mayer New Independent Auditor
4. James B. Hawkins Appointed to IRIDEX Board of Directors
5. Theodore A. Boutacoff Appointed President & CEO of IRIDEX
6. IRIDEX Announces Third Quarter 2007 Conference Call and Release Date
7. IRIDEX Reports Third Quarter Financial Results
8. IRIDEX Announces Fourth Quarter and Full Year 2007 Conference Call and Release Date
9. IRIDEX Reports Fourth Quarter and Full Year 2007 Financial Results
10. IRIDEX Announces First Quarter 2008 Conference Call and Release Date
11. IRIDEX Reports First Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... Boca Raton, FL (PRWEB) , ... January 21, 2017 , ... ... from Germany, announced it is bringing its product to the United States as part ... perfected over the last 25 years, Alcovit aims to reduce the productions of nasty ...
(Date:1/21/2017)... , ... January 21, 2017 , ... ... Alumni Relations, Dianne Travis-Teague, the electrifying line-up of events for its annual meeting ... family, friends, and community. “Coming Home 2017” will be held on Friday ...
(Date:1/21/2017)... ... 21, 2017 , ... The Nobel Biocare™ dental implant company ... for its creos™ line of bone regenerative products. Specifically, the Nobel ... utilizes creos™ allo.gain™ bone graft for a variety of bone reconstruction procedures. In ...
(Date:1/20/2017)... ... January 20, 2017 , ... Source Vitál Apothecary, a skin and body ... oils, announced the company had a successful visit to the 2017 ECRM Diet, Vitamin ... companies that work in the nutritional, sports and health industries a chance to meet ...
(Date:1/20/2017)... ... January 20, 2017 , ... ATP Science, an Australian-based ... recently attended the January ECRM Trade Show in Hilton Head, SC, benefiting from ... large range of supplements that keep the body functioning at its peak performance ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase Inhibitors, Serotonin Receptor Agonists, Sympathomimetic-GABA ... drugs market is expected to grow at a CAGR of ... of 38.7% in the second half of the forecast period. The ... 2016 to 2027. The market is estimated at $1,058 million in ... ...
(Date:1/19/2017)... James Gilbart , ... 2016;12(Suppl 2):3-8; http://www.touchoncology.com/articles/optimising-clinical-outcomes-gastrointestinal-cancers-through-inhibiting-angiogenesis-and ... ... recently in a supplement to European Oncology & ... article by James Gilbart and ...
(Date:1/19/2017)... PALO ALTO, Calif. , Jan. 19, 2017 /PRNewswire/ ... scientific research, is excited to announce that the ... Project: Cancer Biology  (RP:CB) have been published in ... science, this project represents the first practical evaluation ... that result in reproducible studies. Unlike other assessments ...
Breaking Medicine Technology: